Researchers at Case Western Reserve University School of Medicine have developed a method that could make magnetic resonance imaging—MRI—multicolor.
Current MRI techniques rely on a single contrast agent injected into a patient’s veins to vivify images. The new method uses two at once, which could allow doctors to map multiple characteristics of a patient’s internal organs in a single MRI. The strategy could serve as a research tool and even aid disease diagnosis.
“The method we developed enables, for the first time, the simultaneous detection of two different MRI contrast agents,” said Chris Flask, PhD, Associate Professor of Radiology, Biomedical Engineering, and Pediatrics, and Director of the Imaging Resource Core at Case Western Reserve University School of Medicine. Two contrast agents could include one specifically targeting diseased tissue, and one designed to show healthy tissue, for example. The new method would enable immediate comparisons of how each agent distributes in the same patient.
“This multi-agent detection capability has the potential to transform molecular imaging, as it provides a critical translational pathway for studies in patients,” said Flask. It also provides a unique imaging platform to rigorously study molecular therapies.” Therapies could include those targeting biomarkers or other detectable molecules associated with diseases.
Flask and colleagues recently described their new method in Nature Scientific Reports. The paper describes how two contrast agents, gadolinium and manganese, can be detected and independently quantified during MRIs. The authors span 11 departments at Case Western Reserve, uniting engineers, nurses, clinicians, and basic science researchers. They also include several members of the Case Comprehensive Cancer Center. According to the authors, their results provide “an adaptable, quantitative imaging framework to assess two MRI contrast agents simultaneously for a wide variety of imaging applications.”
The researchers have begun to investigate widespread practical applications for the new MRI approach. Said Flask, “In this initial paper, we validated our new methodology, opening the possibility for numerous follow-on application studies in cancer, genetic diseases such as cystic fibrosis, and metabolic diseases such as diabetes.”
Learn more: Multicolor MRIs Could Aid Disease Detection
The Latest on: Multicolor MRIs
- ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwideon November 24, 2021 at 3:30 am
ViewRay, Inc. (NASDAQ: VRAY) today announced, in recognition of Pancreatic Cancer Awareness Month, more than 2,300 pancreatic cancer patients have been treated with MRIdian ...
- Athletes need thorough tests after long COVIDon November 23, 2021 at 9:46 am
Athletes returning to training following long COVID should undergo a series of tests and seek regular advice from a multi-disciplinary team of specialists to ensure they are fit to resume exercise, ...
- Fujifilm to Showcase Expanded Medical Imaging Portfolio at the RSNA 2021 Conferenceon November 23, 2021 at 8:52 am
FUJIFILM Healthcare Americas Corporation announced it will showcase its portfolio of medical imaging solutions at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, held ...
- New mobile MRI unit brings Buckhannon residents improved patient care, close to homeon November 19, 2021 at 12:22 pm
Shorter MRI scan times and higher quality images are now available to local patients right here in Buckhannon thanks to a new mobile MRI unit at WVU Medicine St. Joseph’s Hospital. Buckhannon-Upshur ...
- St. Joseph’s Hospital unveils Mobile MRI Uniton November 16, 2021 at 4:00 pm
St. Joseph’s Hospital welcomed many to the facility’s campus on Tuesday afternoon for a ribbon cutting ceremony to officially recognize their newest addition for expanded patient care—a Mobile MRI ...
- SIU 2021: The Future of Prostate Cancer Imaging: Will AI Play a Role?on November 16, 2021 at 10:09 am
In a Hot Topic session of the Société Internationale D’Urologie (SIU) 2021 annual meeting focused on the role of artificial intelligence (AI) in urology, Dr. Mark Emberton discussed the role of AI in ...
- ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patentson November 16, 2021 at 6:15 am
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued two patents, including U.S.
- Ontario commits to second MRI at Peterborough Regional Health Centreon November 10, 2021 at 12:24 pm
Peterborough-Kawartha PC MPP Dave Smith says the multi-million-dollar commitment is part of the government’s $30-million investment in the 2021 budget to support MRI services and to add new MRI ...
- HeartVista Receives FDA 510(k) Clearance to Deliver One Click MRI™ on Siemens Healthineers MRI Scannerson November 10, 2021 at 6:11 am
“We’re excited to receive FDA 510(k) Clearance for One-Click MRI™ with Siemens scanners, which positions us as a multi-vendor platform for global CMR deployment. This groundbreaking ...
via Google News and Bing News